期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | OncoImmunology LetPub Score 7.8
50 ratings
Rate
Reputation 8.8 Influence 6.8 Speed 9.4 | ||||||||||||||||||||||||
期刊簡稱 | ONCOIMMUNOLOGY | ||||||||||||||||||||||||
ISSN | 2162-4011 | ||||||||||||||||||||||||
E-ISSN | 2162-402X | ||||||||||||||||||||||||
h-index | 58 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 3.10%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://www.tandfonline.com/loi/koni20 | ||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/ONCOIMM | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Landes Bioscience | ||||||||||||||||||||||||
主題領域 | ONCOLOGY | ||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||
發行頻率 | |||||||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||||||
每年文章數 | 114每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 100.00% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2162-4011%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 24 Weeks | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[OncoImmunology] 的評論 | 撰寫評論 |
作者: Journals 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-03-05 11:10:41 評論於 Submitted on August 1, 2023, received first round of major revision comments after 2 months; revised and sent back after 1 month, no time limit set for reviewers to continue review; received second round of major revision comments after 1 and a half months; revised after 1 month, received minor revision comments after around 1 month, and accepted after 3 days. Review was rigorous and feedback was constructive, a great opportunity to humbly learn true knowledge(0) 讚! | Journals |
作者: ILOVER 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2020-12-23 08:20:07 評論於 Submitted at the end of August, and accepted at the end of December. During this period, it underwent a major revision, but without supplementing experiments, only answering the reviewer's questions. We delayed it and resubmitted the revision only after more than a month, and then it was directly accepted after two days. The overall feeling is quite good, processing and reviewing manuscripts are very fast, the impact factor is not bad, and you can try more in the future. (0) 讚! | ILOVER |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us